Company Filing History:
Years Active: 2017-2024
Title: The Innovative Path of Katarzyna Urbanska: Pioneering Universal Immune Receptors
Introduction
Katarzyna Urbanska is an accomplished inventor based in Philadelphia, PA, USA. With a total of five patents to her name, she has significantly contributed to the fields of immunology and adoptive T cell therapy. Her innovative work is paving the way for advanced treatments in various medical disorders, showcasing her expertise and dedication in the realm of scientific research.
Latest Patents
Among her notable inventions is the patent for a universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens. This invention offers compositions and methods for adoptive T cell therapy aimed at treating a range of disorders, including cancer, infections, and autoimmune disorders. In one of its embodiments, the invention comprises a universal immune receptor (UnivIR), which includes an extracellular label binding domain, a transmembrane domain, and either a cytoplasmic domain or an intracellular domain. This innovation highlights her commitment to developing effective therapeutic solutions for complex health challenges.
Career Highlights
Katarzyna Urbanska is affiliated with the University of Pennsylvania, where she conducts her research and continues to make strides in the field of cell therapy and immunology. Her work is not only groundbreaking but also instrumental in advancing scientific understanding and treatment options in her area of expertise.
Collaborations
In her professional journey, Katarzyna collaborates with esteemed colleagues, including Daniel J. Powell and Nathalie Scholler. These collaborations enhance the research efforts and accelerate the process of translating innovative ideas into practical applications, ultimately benefiting patients and the medical community at large.
Conclusion
With her impressive portfolio of patents and collaborations, Katarzyna Urbanska stands out as a leading inventor in the field of immunology. Her ongoing research at the University of Pennsylvania continues to inspire and inform the practices in the innovative therapies targeting complex diseases. Her contributions reflect the potential of innovative thinking to drive change and improve health outcomes for many individuals.